Search Results 651-660 of 18317 for peptides
The purpose of the study is to evaluate the effectiveness, safety and patient-reported outcomes of peptide receptor radionuclide therapy (PRRT) with 177Lu ...
Growth Hormone Releasing Peptide-2 (GHRP-2) tolerance test: peak GH ≤9 ng/mL 3. IGF-1 SDS ≤ -1.0 at screening as measured by central laboratory. 4. hGH ...
Flexbumin® 25% is used when hypovolemia is long-standing and hypoalbuminemia exists along with enough hydration, or fluid swelling (edema). It is also used ...
Glucagon-like Peptide-1 Receptor Agonists in Liver Transplant Recipients: A Retrospective Cohort Study. Transplant Direct. 2026 Apr; 12 (4):e1932 Epub 2026 ...
Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...
Treatment for hypothyroidism usually includes taking the thyroid hormone medicine levothyroxine (Levo-T, Synthroid, others) every day. Research has shown that ...
Vaccines consisting of heat shock protein-peptide complexes made from a person's own tumor tissue may help the body build an effective immune response to kill ...
2020; 29(2):104474. Epub 2019 Nov 26. View PubMed; Chiang CC, Schwedt TJ. Calcitonin gene-related peptide (CGRP)-targeted therapies as preventive and acute ...
... peptide receptor radionuclide therapy, also called PRRT. “It's kind of a 'Trojan horse,'” says Dr. Geoffrey Johnson, chair of the Division of Nuclear ...
... peptide with outcomes after transcatheter aortic valve replacement. Eur J Cardiothorac Surg. 2023 Apr 3; 63 (4) View PubMed; El Sherif N, Dearani JA ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!